Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Xtant Medical Holdings, Inc. | tv478079_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Xtant Medical Holdings, Inc. | tv478079_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Xtant Medical Holdings, Inc. | tv478079_ex31-1.htm |
| EX-10.6 - EXHIBIT 10.6 - Xtant Medical Holdings, Inc. | tv478079_ex10-6.htm |
| 10-Q - FORM 10-Q - Xtant Medical Holdings, Inc. | tv478079_10q.htm |
Exhibit 32.2
Section 1350 Certification of Chief Financial Officer
In connection with the Quarterly Report on Form 10-Q of Xtant Medical Holdings, Inc. (the “Company”) for the quarterly period ended September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Laura Kendall, Deputy CRO of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| /s/ Laura Kendall | |
| Laura Kendall | |
| Deputy CRO | |
| Date: November 21, 2017 |